
Venetoclax and Rituximab Combination
Venetoclax and Rituximab are medications used together to treat certain blood cancers like chronic lymphocytic leukemia (CLL). Venetoclax works by targeting and blocking a protein that cancer cells rely on to survive, leading to their death. Rituximab is a type of antibody that attaches to cancer cells, marking them for destruction by the immune system. Combining these drugs enhances the effectiveness of treatment by attacking cancer cells from different angles, leading to improved outcomes for patients. This combination is carefully managed by healthcare providers to maximize benefits and minimize side effects.